# US 2026/0077094 A1 · Injectable collagen implants and compositions and related systems, and methods of preparation and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077094 A1
- Document ID: US20260077094A1
- Status: Published application
- Kind: A1
- Application number: 19/397,712
- Filed: 2025-11-21
- Published: 2026-03-19
- Earliest claimed: 2024-07-26
- Assignees: Miach Orthopaedics, Inc.
- Applicants: Miach Orthopaedics, Inc.
- Inventors: Stephen WOHLERT; Rita PAPARAZZO
- Web page: https://patentgrep.com/patent/US20260077094A1

## CPC

- A61L 26/0033: {Collagen}
- A61F 2/0805: {Implements for inserting tendons or ligaments}
- A61F 2/0811: {Fixation devices for tendons or ligaments}
- A61F 2/4618: {of cartilage}
- A61L 27/20: Polysaccharides
- A61L 27/24: Collagen
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/3616: {Blood, e.g. platelet-rich plasma}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61M 5/19: having more than one chamber
- A61F 2002/0823: {Modular anchors comprising a plurality of separate parts}
- A61F 2002/0882: {Anchor in or on top of a bone tunnel, i.e. a hole running through the entire bone}
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L 2430/10: for reconstruction of tendons or ligaments
- A61L 2430/24: for joint reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Described herein are collagen slurries and collagen implants suitable for injection into a repair site to repair a tissue, for example, an anterior cruciate ligament, rotator cuff tendon, and/or a meniscus. Further described are systems including collagen implants, methods of preparing collagen slurries and implants, and methods of use thereof.

## Claims

### Claim at position 1

1-77. (canceled)

### Claim 78

A delivery device for tissue repair, comprising:
an elongated body having a proximal end, a distal end, a channel that extends from the proximal end to the distal end, and an actuator in the channel; and
a collagen implant configured for injection into a target tissue, the collagen implant comprising:
a plurality of particles, each particle comprising:
at least one collagen,
at least one salt,
at least one electrolyte, and
at least one glycosaminoglycan,
wherein the collagen implant is housed within the delivery device, and
wherein the actuator is configured to cause the collagen implant to exit the distal end of the body.

### Claim 79 (depends on 78)

The device of claim 78, wherein the elongated body has a port for receiving fluid.

### Claim 80 (depends on 78)

The device of claim 78, wherein the delivery device is a syringe having a single chamber.

### Claim 81 (depends on 78)

The device of claim 78, wherein the delivery device is a syringe having a double chamber.

### Claim at position 6

82-90. (canceled)

### Claim 91 (depends on 78)

The system of claim 78, wherein the at least one collagen is derived from human, bovine, or porcine tissues, or combinations thereof.

### Claim 92 (depends on 78)

The system of claim 78, wherein the at least one collagen comprises Type I, Type II, Type III, Type IV, Type V, Type X, or combinations thereof.

### Claim 93 (depends on 78)

The system of claim 78, wherein the at least one collagen comprises fibrillar collagen, tropocollagen, atelocollagen, heterotrimeric collagen, or combinations thereof.

### Claim 94 (depends on 78)

The system of claim 78, wherein the at least one collagen is in an amount of about 40 w/w % to about 70 w/w %.

### Claim 95 (depends on 78)

The system of claim 78, wherein the at least one collagen is in an amount of greater than 400 mg/g, or about 400 mg/g to about 10,000 mg/g.

### Claim 96 (depends on 78)

The system of claim 78, wherein the at least one collagen is free of crosslinks.

### Claim 97 (depends on 78)

The system of claim 78, wherein each particle of the plurality of particles further comprises a buffer.

### Claim 98 (depends on 97)

The system of claim 97, wherein the buffer is a zwitterionic buffer.

### Claim 99 (depends on 97)

The system of claim 97, wherein the buffer comprises 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), tris(hydroxymethyl)aminomethane) (TRIS), (3-(N-morpholino)propanesulfonic acid) (MOPS), 3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic acid (TAPSO), cacodylate SSC, succinic acid, glycine, sodium phosphate, sodium hydroxide, sodium chloride, magnesium chloride, acetic acid, thrombin buffer, L-ascorbic acid phosphate magnesium salt n-hydrate, MMP-1, MMP-2, MMP-3, MMP-9, RNAase/DNAase, elastase, papain, citrate, sodium citrate, phosphate, saline, or combinations thereof.

### Claim 100 (depends on 78)

The system of claim 78, wherein the at least one salt comprises calcium, magnesium, or combinations thereof.

### Claim 101 (depends on 78)

The system of claim 78, wherein the at least one salt is in an amount of about 2 w/w % to about 5 w/w %.

### Claim 102 (depends on 78)

The system of claim 78, wherein the electrolyte comprises chloride, nitrate, sulfate, silicate, phosphate, aluminate, sodium tetraborate, or combinations thereof.

### Claim 103 (depends on 102)

The system of claim 102, wherein the electrolyte is in an amount of about 5 w/w % to about 11 w/w %.

### Claim 104 (depends on 78)

The system of claim 78, wherein the at least one glycosaminoglycan is in an amount of less than about 2 w/w %, or about 0.001 w/w % to less than about 2 w/w %.

### Claim 105 (depends on 78)

The system of claim 78, wherein the at least one glycosaminoglycan is in an amount of greater than 100 μg/g, or greater than about 100 μg/g to about 8,000 μg/g.

### Claim 106 (depends on 78)

The system of claim 78, wherein each particle of the plurality of particles further comprises a growth factor, peptide, proteinase inhibitor, collagenase inhibitor, zinc ions, retinol, vitamin, steroid, hormone, cytokine, clotting factor, angiogenic protein, antiangiogenic protein, anti-protease protein, bone morphogenic protein, osteoinductive factor, fibronectin, cementum attachment extract, ketanserin, interleukin-1, human alpha thrombin, an anti-inflammatory, or combinations thereof.
